101 related articles for article (PubMed ID: 6232006)
1. Normal and tumor-bearing host macrophage factor-mediated modulation of mixed-lymphocyte reaction responsiveness: separation of T-lymphocyte subset susceptibility to enhancing and inhibitory factors.
Malick AP; Garner RE; Black SP; Elgert KD
Cell Immunol; 1984 May; 85(2):549-55. PubMed ID: 6232006
[TBL] [Abstract][Full Text] [Related]
2. Macrophage-derived prostaglandin E modulation of the mixed-lymphocyte reaction: an anomaly of increased production and decreased T-cell susceptibility during tumor growth.
Denbow CJ; Conroy JM; Elgert KD
Cell Immunol; 1984 Mar; 84(1):1-13. PubMed ID: 6230157
[TBL] [Abstract][Full Text] [Related]
3. Tumor modulation of autoreactivity: decreased macrophage and autoreactive T cell interactions.
Yurochko AD; Burger CJ; Elgert KD
Cell Immunol; 1990 Apr; 127(1):105-19. PubMed ID: 2138515
[TBL] [Abstract][Full Text] [Related]
4. Tumor growth changes the contribution of granulocyte-macrophage colony-stimulating factor during macrophage-mediated suppression of allorecognition.
Walker TM; Yurochko AD; Burger CJ; Elgert KD
Immunobiology; 1992 Sep; 185(5):427-39. PubMed ID: 1452214
[TBL] [Abstract][Full Text] [Related]
5. Tumor-induced variations in a high molecular weight inhibitory monokine.
Malick AP; Yurochko AD; Burger CJ; Askew D; Elgert KD
Immunobiology; 1989 Feb; 178(4-5):361-79. PubMed ID: 2785483
[TBL] [Abstract][Full Text] [Related]
6. Fibrosarcoma-induced increase in macrophage tumor necrosis factor alpha synthesis suppresses T cell responses.
Alleva DG; Askew D; Burger CJ; Elgert KD
J Leukoc Biol; 1993 Aug; 54(2):152-60. PubMed ID: 8360594
[TBL] [Abstract][Full Text] [Related]
7. Modulation of alloreactivity by Mac-1+, -2+, and -3+ macrophages from normal and tumor-bearing hosts: flow cytofluorometrically separated macrophages.
Askew D; Burger CJ; Elgert KD
Immunobiology; 1990 Dec; 182(1):1-10. PubMed ID: 2151512
[TBL] [Abstract][Full Text] [Related]
8. Increased sensitivity of tumor-bearing host macrophages to interleukin-10: a counter-balancing action to macrophage-mediated suppression.
Alleva DG; Burger CJ; Elgert KD
Oncol Res; 1994; 6(4-5):219-28. PubMed ID: 7841545
[TBL] [Abstract][Full Text] [Related]
9. Tumor growth increases Ia- macrophage synthesis of tumor necrosis factor-alpha and prostaglandin E2: changes in macrophage suppressor activity.
Alleva DG; Burger CJ; Elgert KD
J Leukoc Biol; 1993 May; 53(5):550-8. PubMed ID: 8388910
[TBL] [Abstract][Full Text] [Related]
10. Normal and tumor-bearing host splenic macrophage responses to lipopolysaccharide.
Yurochko AD; Askew D; Burger CJ; Elgert KD
Immunol Invest; 1990 Feb; 19(1):41-55. PubMed ID: 1692569
[TBL] [Abstract][Full Text] [Related]
11. Interferon-gamma reduces tumor-induced Ia- macrophage-mediated suppression: role of prostaglandin E2, Ia, and tumor necrosis factor-alpha.
Alleva DG; Burger CJ; Elgert KD
Immunopharmacology; 1993; 25(3):215-27. PubMed ID: 8354638
[TBL] [Abstract][Full Text] [Related]
12. Shifts in macrophage (M phi) surface phenotypes during tumor growth: association of Mac-2+ and Mac-3+ M phi with immunosuppressive activity.
Garner RE; Malick AP; Yurochko AD; Elgert KD
Cell Immunol; 1987 Sep; 108(2):255-68. PubMed ID: 2957065
[TBL] [Abstract][Full Text] [Related]
13. Normal and tumor-bearing host macrophage responses: variability in accessory function, surface markers, and cell-cycle kinetics.
Askew D; Yurochko AD; Burger CJ; Elgert KD
Immunol Lett; 1990; 24(1):21-9. PubMed ID: 1695610
[TBL] [Abstract][Full Text] [Related]
14. Tumor growth alters macrophage responsiveness to macrophage colony-stimulating factor during reactivity against allogeneic and syngeneic MHC class II molecules.
Walker TM; Burger CJ; Elgert KD
Immunol Invest; 1993; 22(6-7):463-76. PubMed ID: 8262568
[TBL] [Abstract][Full Text] [Related]
15. Tumor growth alters T cell and macrophage production of and responsiveness to granulocyte-macrophage colony-stimulating factor: partial dysregulation through interleukin-10.
Walker TM; Burger CJ; Elgert KD
Cell Immunol; 1994 Apr; 154(1):342-57. PubMed ID: 8131207
[TBL] [Abstract][Full Text] [Related]
16. Ia- macrophages and cytokine networks contribute to tumor-induced suppression of CD4+ autoreactive T cells.
Walker TM; Yurochko AD; Burger CJ; Elgert KD
Immunol Invest; 1993 Apr; 22(3):169-87. PubMed ID: 8099569
[TBL] [Abstract][Full Text] [Related]
17. Enhancement of T cell MLR reactivity by addition of macrophage supernatants from tumor-bearing mice.
Elgert KD; Connolly KM
Oncology; 1980; 37(2):101-6. PubMed ID: 6444706
[TBL] [Abstract][Full Text] [Related]
18. Tumor-induced macrophage tumor necrosis factor-alpha production suppresses autoreactive T cell proliferation.
Alleva DG; Burger CJ; Elgert KD
Immunobiology; 1993 Aug; 188(4-5):430-45. PubMed ID: 8244447
[TBL] [Abstract][Full Text] [Related]
19. Induction of macrophage suppressor activity by fibrosarcoma-derived transforming growth factor-beta 1: contrasting effects on resting and activated macrophages.
Alleva DG; Walker TM; Elgert KD
J Leukoc Biol; 1995 Jun; 57(6):919-28. PubMed ID: 7790775
[TBL] [Abstract][Full Text] [Related]
20. Tumor-induced modulation of macrophage class II MHC molecule mRNA expression.
Askew D; Burger CJ; Elgert KD
Mol Immunol; 1993 Jul; 30(10):911-20. PubMed ID: 8341283
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
